The study identifies quinoline-piperazine hybrids to enhance antimalarial efficacy, suggesting new design strategies.
) trends influencing potency, selectivity, and resistance profiles are discussed. These insights will facilitate the rational design and development of novel chemical entities as next-generation antimalarials.
No takes yet. Share an insight, caveat, or question.
Punmiya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: